System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Hermann Brenner is an expert in Oncology at National Center for Tumor Diseases (Germany). As of October 2026, ScienceLeadR ranks Hermann Brenner in the top 1% of experts worldwide for Intestinal Neoplasms, Rectal Diseases and Gastrointestinal Neoplasms. Hermann Brenner has authored 2,552 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 8,117 (community average: 125). How the SLR is computed.

LeadR Profile

Hermann Brenner National Center for Tumor Diseases Germany
8 117 ScienceLeadR Reputation 8117

Unlock

Register Login
Network Map

Oncology

Subspecialties: Public Health - Gastroenterology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1990 - 2026
Source: PubMed

German Cancer Research Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 2552

Citations

Citations: 353 371 1st author: 255 Last author: 810 Unique author: 47

Main journals

Int J Cancer 127
Cancer Epidemiol Biomarkers Prev 67
Br J Cancer 65
Lancet 61
Nat Commun 56

Best Journals

Lancet 56
JAMA 15
Nat Med 10

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Cancer co-medication quality in older patients with polypharmacy: A large randomized trial testing a medication review versus usual care.
PMID 42773858 — research design, polypharmacy, pharmaceutical preparations, internal medicine, neoplasms, pharmacists, rehabilitation, geriatrics		J Intern Med20260
Healthy lifestyle and cancer risk: a pan-cancer analysis in the UK Biobank prospective cohort.
PMID 42744862 — life style, healthy lifestyle, neoplasms, sarcoma, overweight, smoking		Br J Cancer20260
Prediction of incident heart failure in individuals without prior cardiovascular disease: the SCORE2-HF risk model.
PMID 41810943 — diabetes mellitus, heart failure, heart, cardiovascular diseases, cardiology, risk factors, smoking, diabetes mellitus, type 2		Eur Heart J Top journal20266
Examining the Contribution of Childhood Maltreatment to the Sex Gap in Depression: Insights from the German National Cohort (NAKO).
PMID 42671980 — depression, psychosomatic medicine, psychotherapy, prevalence, sex, diagnosis		Psychother Psychosom20260
Can synthetic data reproduce real-world findings in epidemiology? A replication study using adversarial random forests.
PMID 42667682 — epidemiology, privacy, forests, generative artificial intelligence		Int J Epidemiol20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4

By status:

Recruiting 2
Completed 1
Not yet recruiting 1

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 29

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Understanding Lung Cancer Related Risk Factors and Their Impact
NCT06473870 — early diagnosis, lung, neoplasms, lung neoplasms, risk factors, diagnosis		N/ANot yet recruiting2024
The Prostate Cancer Genetic Risk and Equitable Screening Study (ProGRESS)
NCT05926102 — decision making, shared, early detection of cancer, risk assessment, neoplasms, pamphlets, prostate, decision making, biopsy, genetic counseling, prostatic neoplasms, history, counseling, genetic risk score, male, men		N/ARecruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS